JP2023515664A5 - - Google Patents
Info
- Publication number
- JP2023515664A5 JP2023515664A5 JP2022552538A JP2022552538A JP2023515664A5 JP 2023515664 A5 JP2023515664 A5 JP 2023515664A5 JP 2022552538 A JP2022552538 A JP 2022552538A JP 2022552538 A JP2022552538 A JP 2022552538A JP 2023515664 A5 JP2023515664 A5 JP 2023515664A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- double
- nucleotide sequence
- seq
- stranded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026030569A JP2026102645A (ja) | 2020-03-06 | 2026-02-27 | 修飾された短い干渉核酸（ｓｉＮＡ）分子およびそれらの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062986150P | 2020-03-06 | 2020-03-06 | |
| US62/986,150 | 2020-03-06 | ||
| US202063109196P | 2020-11-03 | 2020-11-03 | |
| US63/109,196 | 2020-11-03 | ||
| PCT/US2021/021199 WO2021178885A1 (en) | 2020-03-06 | 2021-03-05 | Modified short interfering nucleic acid (sina) molecules and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026030569A Division JP2026102645A (ja) | 2020-03-06 | 2026-02-27 | 修飾された短い干渉核酸（ｓｉＮＡ）分子およびそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515664A JP2023515664A (ja) | 2023-04-13 |
| JP2023515664A5 true JP2023515664A5 (enExample) | 2024-03-14 |
Family
ID=75278356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552538A Pending JP2023515664A (ja) | 2020-03-06 | 2021-03-05 | 修飾された短い干渉核酸（ｓｉＮＡ）分子およびそれらの使用 |
| JP2026030569A Pending JP2026102645A (ja) | 2020-03-06 | 2026-02-27 | 修飾された短い干渉核酸（ｓｉＮＡ）分子およびそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026030569A Pending JP2026102645A (ja) | 2020-03-06 | 2026-02-27 | 修飾された短い干渉核酸（ｓｉＮＡ）分子およびそれらの使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US20220364096A1 (enExample) |
| EP (1) | EP4121533A1 (enExample) |
| JP (2) | JP2023515664A (enExample) |
| KR (1) | KR20220163960A (enExample) |
| CN (1) | CN115485384A (enExample) |
| AU (1) | AU2021230601A1 (enExample) |
| BR (1) | BR112022017287A2 (enExample) |
| CA (1) | CA3170466A1 (enExample) |
| CL (1) | CL2022002379A1 (enExample) |
| CO (1) | CO2022014258A2 (enExample) |
| GE (2) | GEP20257742B (enExample) |
| IL (1) | IL296045A (enExample) |
| MX (1) | MX2022011012A (enExample) |
| PE (1) | PE20221578A1 (enExample) |
| PH (1) | PH12022552163A1 (enExample) |
| TW (1) | TW202208625A (enExample) |
| WO (1) | WO2021178885A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202002149XA (en) * | 2017-09-14 | 2020-04-29 | Janssen Biopharma Inc | Galnac derivatives |
| JP2023515664A (ja) * | 2020-03-06 | 2023-04-13 | アリゴス セラピューティクス，インコーポレーテッド | 修飾された短い干渉核酸（ｓｉＮＡ）分子およびそれらの使用 |
| WO2022087011A1 (en) | 2020-10-21 | 2022-04-28 | Aligos Therapeutics, Inc. | Bicyclic compounds |
| WO2022184852A1 (en) * | 2021-03-03 | 2022-09-09 | Silence Therapeutics Gmbh | Conjugated nucleic acids comprising a phosphorodithioate for inhibiting gene expression in a cell |
| WO2022266193A1 (en) | 2021-06-18 | 2022-12-22 | Aligos Therapeutics, Inc. | Bicyclic compounds |
| KR20240103025A9 (ko) | 2021-11-16 | 2025-12-10 | 상하이 아르고 바이오파마슈티칼 씨오., 엘티디. | 안지오텐시노겐(agt) 단백질의 발현을 저해하는 조성물 및 방법 |
| WO2023122317A2 (en) * | 2021-12-23 | 2023-06-29 | Aligos Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (SINA) MOLECULES FOR TARGETING β-CATENIN AND USES THEREOF |
| WO2023224979A1 (en) * | 2022-05-16 | 2023-11-23 | University Of Massachusetts | Optimized sirna scaffolds |
| EP4541804A4 (en) * | 2022-06-14 | 2026-07-01 | Rona Bioscience Ltd | Cyclic phosphonate-modified nucleotide |
| WO2024033374A1 (en) | 2022-08-11 | 2024-02-15 | Syngenta Crop Protection Ag | Novel arylcarboxamide or arylthioamide compounds |
| WO2024089216A1 (en) | 2022-10-27 | 2024-05-02 | Syngenta Crop Protection Ag | Novel sulfur-containing heteroaryl carboxamide compounds |
| JP2026500298A (ja) | 2022-12-15 | 2026-01-06 | シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト | 殺有害生物剤として有用である新規な二環式カルボキサミド化合物 |
| AR131541A1 (es) | 2023-01-07 | 2025-04-09 | Syngenta Crop Protection Ag | Compuestos de carboxamida novedosos |
| EP4654973A1 (en) * | 2023-01-26 | 2025-12-03 | Aligos Therapeutics, Inc. | Hepatitis b combination therapies |
| CN121152879A (zh) * | 2023-02-14 | 2025-12-16 | 基愈治疗公司 | 经修饰的双链rna药剂 |
| WO2024254091A1 (en) * | 2023-06-05 | 2024-12-12 | Empirico Inc. | Treatment of fgg related diseases and disorders |
| WO2025032129A1 (en) | 2023-08-08 | 2025-02-13 | Syngenta Crop Protection Ag | Novel aminoindane and aminotetraline compounds |
| CN117024485B (zh) * | 2023-08-11 | 2026-02-13 | 江苏申基生物科技有限公司 | 一种2’-OMe腺苷的合成方法 |
| WO2025096970A2 (en) * | 2023-11-03 | 2025-05-08 | Basecure Therapeutics Llc | Modified oligonucleotides and methods of use thereof |
| CN122228245A (zh) | 2023-11-14 | 2026-06-16 | 先正达农作物保护股份公司 | 新颖的羧酰胺化合物 |
| WO2025109114A1 (en) | 2023-11-24 | 2025-05-30 | Syngenta Crop Protection Ag | Novel carboxamide compounds |
| CN117534717A (zh) * | 2024-01-09 | 2024-02-09 | 凯莱英生命科学技术(天津)有限公司 | 5′-(e)-乙烯基磷酸酯的合成方法 |
| PY2501648A (es) | 2024-01-12 | 2025-10-31 | Syngenta Crop Protection Ag | Nuevos compuestos de carboxamida |
| WO2025149637A1 (en) | 2024-01-12 | 2025-07-17 | Syngenta Crop Protection Ag | Novel carboxamide compounds |
| WO2025201529A1 (en) * | 2024-03-29 | 2025-10-02 | Ractigen Therapeutics | Compounds for synthesizing modified small activating rna molecules, modified small activating rna molecules and uses thereof |
| US20250368996A1 (en) | 2024-05-14 | 2025-12-04 | Aligos Therapeutics, Inc. | Modified antisense oligonucleotides for treating hepatitis b virus |
| WO2025242321A1 (en) | 2024-05-24 | 2025-11-27 | Glaxosmithkline Intellectual Property (No.3) Limited | Novel use |
| WO2026008750A1 (en) | 2024-07-05 | 2026-01-08 | Syngenta Crop Protection Ag | Novel carboxamide compounds |
| CN120796266A (zh) * | 2024-07-08 | 2025-10-17 | 北京悦康科创医药科技股份有限公司 | 一种降低hbv基因表达的反义寡核苷酸及其应用 |
| WO2026120028A1 (en) | 2024-12-04 | 2026-06-11 | Syngenta Crop Protection Ag | Novel heteroaryl carboxamide compounds |
| WO2026119962A1 (en) | 2024-12-04 | 2026-06-11 | Syngenta Crop Protection Ag | Novel phenyl carboxamide compounds |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009002944A1 (en) * | 2007-06-22 | 2008-12-31 | Isis Pharmaceuticals, Inc. | Double strand compositions comprising differentially modified strands for use in gene modulation |
| CN102753187A (zh) * | 2009-06-03 | 2012-10-24 | 戴瑟纳制药公司 | 肽-dicer底物试剂及其特异性抑制基因表达的方法 |
| WO2011139702A2 (en) | 2010-04-28 | 2011-11-10 | Isis Pharmaceuticals, Inc. | Modified nucleosides and oligomeric compounds prepared therefrom |
| PT2726613T (pt) * | 2011-06-30 | 2018-10-26 | Arrowhead Pharmaceuticals Inc | Composições e métodos para inibição da expressão de genes do vírus da hepatite b |
| US9796974B2 (en) * | 2011-11-18 | 2017-10-24 | Alnylam Pharmaceuticals, Inc. | Modified RNAi agents |
| EP3109254B1 (en) * | 2014-02-18 | 2018-04-11 | Osaka University | Crosslinked nucleoside and nucleotide |
| CN115957337A (zh) * | 2015-08-07 | 2023-04-14 | 箭头药业股份有限公司 | 乙型肝炎病毒感染的RNAi疗法 |
| IL308717A (en) * | 2015-12-07 | 2024-01-01 | Genzyme Corp | Methods and compositions for treating a serpinc1-associated disorder |
| EP3387129A1 (en) * | 2015-12-10 | 2018-10-17 | Alnylam Pharmaceuticals, Inc. | STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF |
| JOP20170056B1 (ar) | 2016-09-02 | 2021-08-17 | Arrowhead Pharmaceuticals Inc | مركبات ترابطية مستهدفة |
| WO2018045317A1 (en) | 2016-09-02 | 2018-03-08 | Dicerna Pharmaceuticals, Inc. | 4'-phosphate analogs and oligonucleotides comprising the same |
| US11015198B2 (en) * | 2017-04-05 | 2021-05-25 | Silence Therapeutics Gmbh | Products and compositions |
| US11324820B2 (en) * | 2017-04-18 | 2022-05-10 | Alnylam Pharmaceuticals, Inc. | Methods for the treatment of subjects having a hepatitis b virus (HBV) infection |
| HRP20250277T1 (hr) * | 2017-12-01 | 2025-05-09 | Suzhou Ribo Life Science Co., Ltd. | Dvolančani oligonukleotid, sastav i konjugat koji sadrži dvolančani oligonukleotid, postupak njihove pripreme i upotreba |
| CN118638787A (zh) * | 2017-12-06 | 2024-09-13 | 艾维迪提生物科学公司 | 治疗肌萎缩和强直性肌营养不良的组合物和方法 |
| CA3098623A1 (en) * | 2018-05-07 | 2019-11-14 | Alnylam Pharmaceuticals, Inc. | Extrahepatic delivery |
| WO2019217397A2 (en) * | 2018-05-07 | 2019-11-14 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for improving strand biased |
| US20200147124A1 (en) | 2018-11-08 | 2020-05-14 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| JP2023515664A (ja) * | 2020-03-06 | 2023-04-13 | アリゴス セラピューティクス，インコーポレーテッド | 修飾された短い干渉核酸（ｓｉＮＡ）分子およびそれらの使用 |
-
2021
- 2021-03-05 JP JP2022552538A patent/JP2023515664A/ja active Pending
- 2021-03-05 GE GEAP202116053A patent/GEP20257742B/en unknown
- 2021-03-05 CN CN202180032666.3A patent/CN115485384A/zh active Pending
- 2021-03-05 WO PCT/US2021/021199 patent/WO2021178885A1/en not_active Ceased
- 2021-03-05 MX MX2022011012A patent/MX2022011012A/es unknown
- 2021-03-05 BR BR112022017287A patent/BR112022017287A2/pt unknown
- 2021-03-05 PH PH1/2022/552163A patent/PH12022552163A1/en unknown
- 2021-03-05 EP EP21715377.4A patent/EP4121533A1/en active Pending
- 2021-03-05 IL IL296045A patent/IL296045A/en unknown
- 2021-03-05 GE GEAP202416053A patent/GEAP202416053A/en unknown
- 2021-03-05 CA CA3170466A patent/CA3170466A1/en active Pending
- 2021-03-05 TW TW110108015A patent/TW202208625A/zh unknown
- 2021-03-05 KR KR1020227034100A patent/KR20220163960A/ko active Pending
- 2021-03-05 PE PE2022001900A patent/PE20221578A1/es unknown
- 2021-03-05 US US17/194,079 patent/US20220364096A1/en active Pending
- 2021-03-05 AU AU2021230601A patent/AU2021230601A1/en active Pending
-
2022
- 2022-02-15 US US17/672,268 patent/US11549110B2/en active Active
- 2022-09-01 CL CL2022002379A patent/CL2022002379A1/es unknown
- 2022-10-05 CO CONC2022/0014258A patent/CO2022014258A2/es unknown
- 2022-11-29 US US18/059,561 patent/US20230332153A1/en active Pending
-
2023
- 2023-07-28 US US18/361,363 patent/US12129469B2/en active Active
-
2026
- 2026-02-27 JP JP2026030569A patent/JP2026102645A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7798836B2 (ja) | Ｂ型肝炎感染の治療用のＰＡＰＤ５及びＰＡＰＤ７ ｍＲＮＡを低減させるための核酸分子 | |
| JP2023068035A5 (enExample) | ||
| JP3529135B2 (ja) | 特定のｒｎａ鎖の切断方法 | |
| JP3330595B2 (ja) | ウィルス（ｈｉｖ）増殖抑制 | |
| WO1996006104A1 (en) | Polynucleotide reagents having nonnucleotidic moieties, and associated methods of synthesis and use | |
| JP2023011793A5 (enExample) | ||
| JP2021533804A5 (enExample) | ||
| JP2024531728A5 (enExample) | ||
| JP2017535552A5 (enExample) | ||
| JP2018530529A5 (enExample) | ||
| JP2005517427A5 (enExample) | ||
| WO1998000564A1 (en) | Methods and compositions for sequence-specific hybridization of rna by 2'-5' oligonucleotides | |
| CA2024182A1 (en) | Probes | |
| JP2006502694A5 (enExample) | ||
| JP2024535797A5 (enExample) | ||
| CN121079412A (zh) | 经修饰的指导rna | |
| JP2024523702A5 (enExample) | ||
| RU2020135289A (ru) | Применение ингибиторов fubp1 для лечения инфекции вирусом гепатита в | |
| CN115698288A (zh) | 核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途 | |
| JP2008500817A5 (ja) | Ｄｎａウイルスのマイクロｒｎａ及びそれを阻害する医薬品 | |
| WO2024040041A1 (en) | Regulation of activity of rnai molecules | |
| EP4729072A1 (en) | Galnac monomer comprising ribose ring or derivative structure thereof and use thereof in liver-targeted delivery of small nucleic acid drugs | |
| JP2025509552A5 (enExample) | ||
| US6136965A (en) | Deoxynucleic alkyl and alkoxy thiourea compounds | |
| JP2025518522A5 (enExample) |